S25-418 Novel Dual Chelator Targeted Radioligand Therapy of Metastatic Castration Resistant Prostate Cancer (mCRPC) Metastatic castration resistant prostate cancer (mCRPC) is an advanced stage of prostate cancer managed with a combination of various therapeutics. Hong Song Arutselvan Natarajan
S12-506 Novel PET imaging agents for the detection of CA6 epitope in-vivo Stanford researchers have developed new imaging agents for the detection of the CA6 epitope in vivo in cancer patients. Sanjiv Gambhir Ohad Ilovich Richard Kimura Arutselvan Natarajan Jochen Kruip Susanta Sarkar Mathias Gebauer Christian Lange Ingo Focken